A Study Screening Mammograms for Women in Their 40s: Mammography Choice

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 13-003966
    Sponsor Protocol Number: 13-003966

About this study

The purpose of this study is to help women in their late 30s and in their 40s, make decisions regarding breast cancer screening that align with each women’s values and preferences. 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Observations of Clinical Encounters
    • Clinicians
      • PCIM and FM at Mayo Clinic, Rochester and Kasson and MCHS
  • Field Testing & Iterative Development
    • Women
      • Adult women aged 39-49
      • Medical exam visit scheduled with eligible clinician
  • Field Testing & Iterative Development through Focus Groups
    • Women
    • Adult women aged 30-49

Exclusion Criteria:

  • Observations of Clinical Encounters
    • Clinicians
      • None
  • Field Testing & Iterative Development
    • Women
      • Major barriers to participate in shared decision making or to providing informed consent (i.e. dementia, severe hearing or visual impairment)
      • Personal history of breast cancer, LCIS, or atypia (ADH/ALH), or suspected or known BRCA 1 or 2 mutations
      • Initially will exclude women with known breast density of D3 or higher
  • Field Testing & Iterative Development through Focus Groups
    • Major barriers to participate in shared decision making or to providing informed consent (i.e. dementia, severe hearing or visual impairment)

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Summer Allen, M.D.

Closed for enrollment

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions